NephroPlus founder Vikram Vuppala at a press conference in Visakhapatnam. File
| Photo Credit: The Hindu
Dialysis services provider Nephrocare Health Services, better known by its NephroPlus brand, has filed draft red herring prospectus (DRHP) with capital markets regulator SEBI to raise funds through an initial public offering (IPO).
The IPO proposed by the Hyderabad based company will be a combination of a fresh issue of equity shares aggregating up to ₹353.4 crore and an offer for sale (OFS) of nearly 1.28 crore equity shares by the selling shareholders.
The company proposes to utilise the net proceeds of the fresh issue towards capital expenditure of ₹129.1 crore for opening new dialysis clinics in India; ₹136 crore for pre-payment or scheduled repayment of certain borrowings availed by the company and rest on general corporate purposes.
Incorporated in 2009, it is the largest organised dialysis service network in India, having 447 clinics across 269 cities in 21 States and 4 Union Territories . It is also present in Philippines, Uzbekistan, Nepal and recently entered the Middle East market through Saudi Arabia.
The company may consider a pre-IPO placement for upto ₹70.6 crore. Vikram Vuppala, BVP (Bessemer Venture Partners) Trust, Edoras Investment Holdings Pte., Healthcare Parent (HPL), Investcorp Private Equity Fund II (IPEF II) and Investcorp Growth Opportunity Fund (IGOF) are promoters of the company.
In FY25, NephroPlus reported revenue from operations of ₹755.8 crore and profit after tax of ₹67 crore.
Published – July 26, 2025 06:42 pm IST
